The page is the record's research on the issuer — no analyst, no rating, no view. # Scribe Therapeutics, Inc. (NASDAQ: SCTX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Scribe Therapeutics, Inc. is listed on NASDAQ under the ticker SCTX. Its ISIN is US8110331092. Its LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. Its security type is Corporate, its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is United States, Delaware. Its segment is not on the record. Its listing status is listed, not halted. ## The disclosure read The record holds 45 filings in the twelve months from 2025-11-08 to 2026-11-08, across 16 filing days. The median gap between filing days is 3 days. The latest filing is a results filing dated 2026-09-02, which is 67 days before the record date of 2026-11-08. The NASDAQ median cadence gap is 6.0 days, the NASDAQ median of filings is 52, and the NASDAQ median latency is 5.0 days. The sector median cadence gap is 5.5 days, the sector median of filings is 65.5, and the sector median latency is 4.0 days. Of the 45 filings, 25 are directors dealings, 12 are regulatory filings, 5 are prospectuses, 2 are results and 1 is ad hoc. ## Auditor The auditor of record is not on the record, as the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds two listing lines, dated 2026-07-21 and 2026-07-22. The record holds no delisting and no name change. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable, as the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The vintage is sealed. The issuer's sealed years are 2021 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001853921.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/SCTX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/SCTX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/SCTX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp